Lorrie A Kirshenbaum

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Top Venues

Cardiovascular research

Canadian journal of physiology and pharmacology

Circulation research

This page only lists publications with an associated author ORCID identifier.

Publications

Inna Rabinovich-Nikitin, Shuangbo Liu, Lorrie A Kirshenbaum
Sex-specific considerations in cardiovascular drug therapy. Canadian journal of physiology and pharmacology 102 (9) (2024)
Inna Rabinovich-Nikitin, Molly Crandall, Lorrie A Kirshenbaum
Circadian-Regulated GR Signaling Mediates Morning Arrhythmias. Circulation research 134 (10) (2024)
Matthew Guberman, Rimpy Dhingra, Jenna Cross, Victoria Margulets, Hongying Gang, Inna Rabinovich-Nikitin, Lorrie A Kirshenbaum
IKKβ stabilizes Mitofusin 2 and suppresses doxorubicin cardiomyopathy. Cardiovascular research 120 (2) (2024)
Inna Rabinovich-Nikitin, Molly Crandall, Lorrie A Kirshenbaum
Circadian-Regulated GR Signaling Mediates Morning Arrhythmias. Circulation research 134 (10) (2024)
Matthew Guberman, Rimpy Dhingra, Jenna Cross, Victoria Margulets, Hongying Gang, Inna Rabinovich-Nikitin, Lorrie A Kirshenbaum
IKKβ stabilizes Mitofusin 2 and suppresses doxorubicin cardiomyopathy. Cardiovascular research (2024)
Inna Rabinovich-Nikitin, Shuangbo Liu, Lorrie A Kirshenbaum
Sex-specific considerations in cardiovascular drug therapy. Canadian journal of physiology and pharmacology 102 (9) (2024)
Inna Rabinovich-Nikitin, Shuangbo Liu, Lorrie A Kirshenbaum
Sex-specific considerations in cardiovascular drug therapy. Canadian journal of physiology and pharmacology (2024)
Matthew Guberman, Rimpy Dhingra, Jenna Cross, Victoria Margulets, Hongying Gang, Inna Rabinovich-Nikitin, Lorrie A Kirshenbaum
IKKβ stabilizes Mitofusin 2 and suppresses doxorubicin cardiomyopathy. Cardiovascular research 120 (2) (2024)
Inna Rabinovich-Nikitin, Lorrie A Kirshenbaum
BMAL1 regulates cell cycle progression and angiogenesis of endothelial cells. Cardiovascular research (2023)
Rimpy Dhingra, Ali Javaheri, Abhinav Diwan, Lorrie A Kirshenbaum
Response by Dhingra et al to Letter Regarding Article, "Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy". Circulation 147 (13) (2023)
Rimpy Dhingra, Ali Javaheri, Abhinav Diwan, Lorrie A Kirshenbaum
Response by Dhingra et al to Letter Regarding Article, "Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy". Circulation 147 (13) (2023)
Rimpy Dhingra, Ali Javaheri, Abhinav Diwan, Lorrie A Kirshenbaum
Response by Dhingra et al to Letter Regarding Article, "Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy". Circulation 147 (13) (2023)
Rimpy Dhingra, Lorrie A Kirshenbaum
Unc51-like-kinase 1-mediated mitophagy prevents pathological cardiac remodelling and heart failure. Cardiovascular research 118 (12) (2022)
Rimpy Dhingra, Inna Rabinovich-Nikitin, Sonny Rothman, Matthew Guberman, Hongying Gang, Victoria Margulets, Davinder S Jassal, Keshav Narayan Alagarsamy, Sanjiv Dhingra, Carla Valenzuela Ripoll, Filio Billia, Abhinav Diwan, Ali Javaheri, Lorrie A Kirshenbaum
Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy. Circulation 146 (12) (2022)
Inna Rabinovich-Nikitin, Lorrie A Kirshenbaum
Rev-erb-Mediated Regulation of Cardiac Metabolism in the Obesity Paradox. Circulation 145 (6) (2022)
Inna Rabinovich-Nikitin, Rachel C Cogan, Lorrie A Kirshenbaum
Attenuation of Obesity Cardiomyopathy by Ulk1/Rab9 Mediated Alternative Mitophagy. Circulation research 129 (12) (2021)